Cargando…
Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer’s disease-like pathologies in APP/PS1 mouse model
OBJECTIVE: Alzheimer's disease (AD) is along with cognitive decline due to amyloid-β (Aβ) plaques, tau hyperphosphorylation, and neuron loss. Shenqi Xingnao Granules (SQXN), a traditional Chinese medicine, significantly ameliorated the cognitive function and daily living abilities of patients w...
Autores principales: | Yang, Cui-cui, Jia, Xiao-yu, Zhang, Li, Li, Ya-li, Zhang, Zhan-jun, Li, Lin, Zhang, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476633/ https://www.ncbi.nlm.nih.gov/pubmed/36120170 http://dx.doi.org/10.1016/j.chmed.2020.04.005 |
Ejemplares similares
-
Shenqi Jiangtang Granule Ameliorates Kidney Function by Inhibiting Apoptosis in a Diabetic Rat Model
por: Zhang, Qian, et al.
Publicado: (2019) -
Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions
por: Qiao, Ou, et al.
Publicado: (2021) -
Network Pharmacology and Molecular Docking-Based Strategy to Investigate the Multitarget Mechanisms of Shenqi Yizhi Granule on Alzheimer's Disease
por: Wang, Linshuang, et al.
Publicado: (2022) -
Meta-Analysis of the Therapeutic Effect of Shenqi Jiangtang Granule on Type 2 Diabetes Mellitus
por: Li, Ruo-Lan, et al.
Publicado: (2020) -
Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model
por: Chen, Qingyou, et al.
Publicado: (2021)